Item 9A. Controls and Procedures
ITEM 9A. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures
that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act,
such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms.
Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management,
including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying
Officers”), the effectiveness of our disclosure controls and procedures as of December 31, 2022, pursuant to Rule 13a-15(b) under
the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of December 31, 2022, our disclosure controls
and procedures were effective.
We do not expect that our
disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how
well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures
are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the
benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no
evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and
instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions.
Management’s Report on Internal Controls Over Financial Reporting
This Annual Report on Form
10-K does not include a report of management’s assessment regarding internal control over financial reporting or an attestation
report of our independent registered public accounting firm due to a transition period established by rules of the SEC for newly public
companies.
Changes in Internal Control over Financial Reporting
There were no changes in
our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the
most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.
ITEM 9B. OTHER INFORMATION
None.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
INSPECTIONS
Not applicable.
16
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The following table sets forth information about
our directors and executive officers:
Name
Age
Position
Jiande Chen
67
Chief Executive Officer and Chairman of the Board
Edward Cong Wang
39
Chief Financial Officer and Director
Raymond J. Gibbs
68
Director
Wei Kwang Ng
42
Director
Hong Li
59
Director
Jiande Chen has been
our Chief Executive Officer and Chairman of the Board since January 2022. Mr. Chen has served as a non-executive director at IMAX China
Holding, Inc. (HKG: 1970) since January 2021 and an independent director at Beijing Cultural Investment Development Group Co., Ltd. (SHA:
600715) since June 2017. Mr. Chen is also a member of the board of directors at TCL-IMAX Entertainment Co., Limited, a joint venture of
TCL Corporation and IMAX Corporation. Mr. Chen served as the chief executive officer from August 2011 to December 2019 and the vice chairman
from December 2019 to December 2020 of IMAX China Holding, Inc. (HKG: 1970), and led IMAX China to complete its first initial offering
on Hong Kong Exchanges. Mr. Chen was previously the Senior Vice President, Chief Representative and General Manager of Sony Pictures Entertainment,
China from 2000 to 2011. Mr. Chen received a degree in English Literature from Fudan University in 1982. Mr. Chen received a master’s
degree and a Ph.D. degree in Communications from University of Washington in 1987 and 1991, respectively.
Edward Cong Wang has been our Chief Financial Officer and a member of our board of directors
since January 2022. Mr. Wang has also served as the managing partner at The Balloch (Holding) Group since March 2020. Before that, he
was a partner at Prestige Financial Holdings Group Limited from August 2018 to September 2019. Mr. Wang served as a partner at Shenzhen
Bode Chuangfu Investment Management Co. Ltd., from January 2017 to July 2018. Mr. Wang served as the chief executive officer of ZS Fur
& Leather Fashion Co., a family owned business, from July 2014 to December 2016. Prior to ZS Fur, he worked at Merrill Lynch, Pierce,
Fenner & Smith Incorporated as a vice president from July 2011 to June 2014. Mr. Wang received a bachelor’s degree in Economics/Finance
from Stony Brook State University in 2006 and graduated with a master’s degree of Statistics from Columbia University in 2010.
Raymond J. Gibbs has
been a member of our board of directors since January 2022. He has
spent the last 21 years as chief financial officer or commercial director of high technology and fast moving consumer goods businesses
both in the quoted and private arenas. Mr. Gibbs has co-chaired the UK-China Joint Working Group on Graphene Standardization, organized
by the BSI Group and the China Standards Authority, and he has served as the chairman of planarTECH LLC since July 2019. In addition,
he served as the president of business development and the chief executive officer of Haydale Graphene Industries PLC, a publicly listed
company in the UK, from May 2010 to July 2019. Mr. Gibbs is a Chartered Accountant. Mr. Gibbs received a bachelor’s degree from
Nottingham Trent University in 1977.
Wei Kwang Ng has been
a member of our board of directors since January 2022. He has held the position of Chief Operating Officer of Parcel Santa Pte Ltd since
July 2017. Mr. Ng was the Director of Operations of World Marketing Group Pte Ltd. from March 2019 to March 2020. He was the Managing
Director of LegalFocus Consultants, Inc. from 2011 to 2018. He worked in Merrill Brink International as the project manager from May 2008
to March 2011. Mr. Ng received bachelor’s degrees in Business Management with a concentration in Finance and in Economics from Stony
Brook State University in 2007.
Hong Li has been a
member of our board of directors since February 2022. Mr. Li has served as the CEO at Shanghai Sycamore Asset Management since 2021. Previously,
he was the Chief Digital Officer and Chief Product Strategy Officer of Noah Holdings Limited (NYSE: NOAH) from April 2020 to March 2021.
At the same time period, he was also the Chief Operating Officer in Gopher Asset Management. Before that, Mr. Li had served as the Chief
Product Officer of Lufax Holding Ltd (NYSE: LU) from April 2018 to December 2019 and the Chairman of CITCO Fund Service from May 2010
to November 2015. Mr. Li received a bachelor’s degree in Physics from Zhongshan University in 1984, a master’s degree in Electronic
Engineering from Zhongshan University in 1989 and a master’s degree in Computer Science from University of San Francisco in 1993.
He also achieved Executive certificate in Management and Leadership from MIT in 2010 and EMBA from China Europe International Business
School in 2015.
17
Number and Terms of Office of Officers and Directors
Our board of directors consists
of five directors. Each member of our board of directors will be elected at our annual meetings. In accordance with Nasdaq corporate governance
requirements, we are not required to hold an annual meeting until one year after our first fiscal year end following our listing on Nasdaq.
Our officers are appointed
by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of
directors is authorized to appoint persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our
officers may consist of a Chairman of the Board, Chief Executive Officer, Chief Financial Officer, President, Vice Presidents, Secretary,
Treasurer and such other offices as may be determined by the board of directors.
Director Independence
Nasdaq requires that a majority
of our board must be composed of “independent directors,” which is defined generally as a person other than an officer or
employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company’s
board of directors would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of
a director. Raymond J. Gibbs, Wei Kang Ng and Hong Li are each considered an “independent director” under the Nasdaq listing
rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.
We will only enter into a
business combination if it is approved by a majority of our independent directors. Additionally, we will only enter into transactions
with our officers and directors and their respective affiliates that are on terms no less favorable to us than could be obtained from
independent parties. Any related-party transactions must also be approved by our audit committee and a majority of disinterested independent
directors.
Committees of the Board of Directors
Our board of directors have
three standing committees: an audit committee, a compensation committee, and a nominating committee. Subject to phase-in rules and a limited
exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of
independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent
directors.
Audit Committee
We have established an audit
committee of the board of directors, which consists of Raymond J. Gibbs, Wei Kang Ng and Hong Li, each of whom is an independent director
under Nasdaq’s listing standards and under Rule 10-A-3(b)(1) of the Exchange Act. Raymond J. Gibbs is the Chairperson of the audit
committee. The audit committee’s duties, which are specified in our Audit Committee Charter, include, but are not limited to:
● reviewing
and discussing with management and the independent auditor the annual audited financial statements,
and recommending to the board whether the audited financial statements should be included
in our Form 10-K;
● discussing
with management and the independent auditor significant financial reporting issues and judgments
made in connection with the preparation of our financial statements;
● discussing
with management major risk assessment and risk management policies;
● monitoring
the independence of the independent auditor;
18
● verifying
the rotation of the lead (or coordinating) audit partner having primary responsibility for
the audit and the audit partner responsible for reviewing the audit as required by law;
● reviewing
and approving all related-party transactions;
● inquiring
and discussing with management our compliance with applicable laws and regulations;
● pre-approving
all audit services and permitted non-audit services to be performed by our independent auditor,
including the fees and terms of the services to be performed;
● appointing
or replacing the independent auditor;
● determining
the compensation and oversight of the work of the independent auditor (including resolution
of disagreements between management and the independent auditor regarding financial reporting)
for the purpose of preparing or issuing an audit report or related work;
● establishing
procedures for the receipt, retention and treatment of complaints received by us regarding
accounting, internal accounting controls or reports which raise material issues regarding
our financial statements or accounting policies; and
● approving
reimbursement of expenses incurred by our management team in identifying potential target
businesses.
Financial Experts on Audit Committee
Pursuant to Nasdaq rules,
the audit committee will at all times be composed exclusively of “independent directors” who are “financially literate”
as defined under the Nasdaq listing standards. The Nasdaq listing standards define “financially literate” as being able to
read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement.
In addition, we must certify
to Nasdaq that the committee has, and will continue to have, at least one member who has past employment experience in finance or accounting,
requisite professional certification in accounting, or other comparable experience or background that results in the individual’s
financial sophistication. The board of directors has determined that Raymond J. Gibbs qualifies as an “audit committee financial
expert,” as defined under rules and regulations of the SEC.
Compensation Committee
We have established a compensation
committee of the board of directors, which consists of Raymond J. Gibbs, Wei Kang Ng and Hong Li, each of whom is an independent director
under Nasdaq’s listing standards. Raymond J. Gibbs is the Chairperson of the compensation committee. The compensation committee’s
duties, which are specified in our Compensation Committee Charter, include, but are not limited to:
● reviewing
and approving on an annual basis the corporate goals and objectives relevant to our Chief
Executive Officer and Chief Financial Officer’s compensation, evaluating our Chief
Executive Officer and Chief Financial Officer’s performance in light of such goals
and objectives and determining and approving the remuneration (if any) of our Chief Executive
Officer and Chief Financial Officer based on such evaluation;
● reviewing
and approving the compensation of all of our other executive officers;
19
● reviewing
our executive compensation policies and plans;
● implementing
and administering our incentive compensation equity-based remuneration plans;
● assisting
management in complying with our proxy statement and annual report disclosure requirements;
● approving
all special perquisites, special cash payments and other special compensation and benefit
arrangements for our executive officers and employees;
● producing
a report on executive compensation to be included in our annual proxy statement; and
● reviewing,
evaluating and recommending changes, if appropriate, to the remuneration for directors.
The charter also provides
that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or
other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However,
before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee
will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Nominating Committee
We have established a corporate
governance and nominating committee (the “nominating committee”) of the board of directors, which consists of Raymond J. Gibbs,
Wei Kang Ng and Hong Li, each of whom is an independent director under Nasdaq’s listing standards. Raymond J. Gibbs is the Chairperson
of the nominating committee. The nominating committee is responsible for overseeing the selection of persons to be nominated to serve
on our board of directors and ensure the Company has and follows appropriate corporate governance practices and standards. The nominating
committee considers persons identified by its members, management, stockholders, investment bankers and others.
Guidelines for Selecting Director Nominees
The guidelines for selecting
nominees, which are specified in the Nominating Committee Charter, generally provide that persons to be nominated:
● should
have demonstrated notable or significant achievements in business, education or public service;
● should
possess the requisite intelligence, education and experience to make a significant contribution
to the board of directors and bring a range of skills, diverse perspectives and backgrounds
to its deliberations; and
● should
have the highest ethical standards, a strong sense of professionalism and intense dedication
to serving the interests of the stockholders
The nominating committee
will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism
in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills
or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider
the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not
distinguish among nominees recommended by stockholders and other persons.
Code of Ethics
We have adopted a code of
ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the business and ethical principles
that govern all aspects of our business. You will be able to review our Code of Ethics by accessing our public filings at the SEC’s
web site at www.sec.gov. In addition, a copy of our Code of Ethics will be provided without charge upon request from us. We intend to
disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K.
20
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities
Exchange Act of 1934, as amended, or the Exchange Act, requires our executive officers, directors and persons who beneficially own more
than 10% of a registered class of our equity securities to file with the Securities and Exchange Commission initial reports of ownership
and reports of changes in ownership of our shares of common stock and other equity securities. These executive officers, directors, and
greater than 10% beneficial owners are required by SEC regulation to furnish us with copies of all Section 16(a) forms filed by such reporting
persons.
Based solely on our review
of such forms furnished to us and written representations from certain reporting persons, we believe that all filing requirements applicable
to our executive officers, directors and greater than 10% beneficial owners were filed in a timely manner.
ITEM 11. EXECUTIVE COMPENSATION
Employment Agreements
We have not entered into
any employment agreements with our executive officers and have not made any agreements to provide benefits upon termination of employment.
Executive Officers and Director Compensation
No executive officer has
received any cash compensation for services rendered to us. Other than the monthly administrative expenses of $10,000 as described in
this Report, no compensation of any kind, including finders, consulting or other similar fees, will be paid to any of our existing stockholders,
including our directors, or any of their respective affiliates, prior to, or for any services they render in order to effectuate, the
consummation of a business combination. However, such individuals will be reimbursed for any out-of-pocket expenses incurred in connection
with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations.
There is no limit on the amount of these out-of-pocket expenses and there will be no review of the reasonableness of the expenses by anyone
other than our board of directors and audit committee, which includes persons who may seek reimbursement, or a court of competent jurisdiction
if such reimbursement is challenged.
Compensation Committee Interlocks and Insider Participation
None of our officers currently
serves, or in the past year has served, as a member of the compensation committee of any entity that has one or more officers serving
on our board of directors.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
The following table sets forth
as of April 7, 2023 the number of shares of common stock beneficially owned by (i) each person who is known by us to be the beneficial
owner of more than five percent of our issued and outstanding shares of common stock; (ii) each of our officers and directors; and (iii)
all of our officers and directors as a group. As of April 7, 2023, we had 8,801,650 shares of common stock issued and outstanding.
Unless otherwise indicated, we
believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially
owned by them. The following table does not reflect record of beneficial ownership of any shares of common stock issuable upon exercise
of the warrants or conversion of the rights, as the warrants are not exercisable and the rights are not convertible within 60 days of
April 7, 2023.
21
Number of
Shares
Percentage of
Beneficially
Outstanding
Name and Address of Beneficial Owner (1)
Owned
Shares
Jiande Chen
45,000
*
Edward Cong Wang
35,000
*
Raymond J. Gibbs
35,000
*
Wei Kwang Ng
30,000
*
Hong Li
30,000
*
All officers and directors as a group (5 individuals)
175,000
2.0 %
Redwoods Capital LLC (2)
3,115,000
35.4 %
MMCAP International Inc. SPC (3)
800,000
9.1 %
MM Asset Management Inc. (3)
800,000
9.1 %
* Less than one percent.
(1) Unless otherwise indicated, the business address of each of
the individuals is c/o Redwoods Acquisition Corp., 1115 Broadway 12th Floor, New York, NY 10010.
(2) Redwoods Capital LLC, a Delaware limited liability company,
our sponsor, is controlled by Min Gan.
(3) Based on a Schedule 13G filed April 7, 2022, MMCAP International
Inc. SPC and MM Asset Management Inc. have shared voting power over these shares. The address of MMCAP International Inc. SPC is c/o
Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, P.O. Box 1348, Grand Cayman, KY1-1108, Cayman Islands and
the address of MM Asset Management Inc. is 161 Bay Street, TD Canada Trust Tower Ste 2240, Toronto, ON M5J 2S1 Canada.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
Founder Shares
On January 4, 2022, we issued
2,875,000 shares of common stock (the “insider shares”) to the Sponsor and certain of our executive officers and directors
for an aggregated consideration of $25,000, or approximately $0.009 per share. Prior to the initial investment of $25,000 in us, we had
no assets, tangible or intangible. The per share purchase price of the insider shares was determined by dividing the amount of cash contributed
to us by the aggregate number of insider shares issued.
Related Party Loans
On January 4, 2022 and February
28, 2022, the Sponsor agreed to loan us up to an aggregate amount of $200,000 to be used, in part, for transaction costs incurred in connection
with the IPO (the “promissory notes”). The promissory notes were unsecured, interest-free and due on the closing the IPO.
We repaid the outstanding balance of $200,000 to the Sponsor on April 7 and April 8, 2022.
On March 22, 2023, we issued
an unsecured, non-interest bearing promissory note in the principal amount of up to $150,000 to Redwoods Capital LLC, the Company’s
sponsor. The note is payable upon the closing of the Company’s initial business combination or the liquidation of the Company. The
holder of the note, in its sole discretion, may convert any or all of the unpaid principal under the note into private units of the Company,
at a price of $10.00 per unit, upon consummation of the Company’s initial business combination.
On March 30, 2023, we issued
an unsecured, non-interest bearing promissory note in the principal amount of up to $360,000 to Redwoods Capital LLC, the Company’s
sponsor. The note is payable upon the closing of the Company’s initial business combination or the liquidation of the Company. The
holder of the note, in its sole discretion, may convert any or all of the unpaid principal under the note into private units of the Company,
at a price of $10.00 per unit, upon consummation of the Company’s initial business combination.
Working Capital Loans
In order to meet our working
capital needs following the consummation of the IPO and in connection with an intended initial business combination, our insiders, officers,
and directors may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of our initial
business combination, without interest, or, at the lender’s discretion, up to $500,000 of the notes may be converted upon consummation
of our business combination into private units at a price of $10.00 per unit. If we do not complete a business combination, any outstanding
loans from our insiders, officers and directors or their affiliates, will be repaid only from amounts remaining outside our trust account,
if any.
22
Administrative Services Agreement
We have agreed to pay the
Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative services commencing on the date that
the securities were first listed on the Nasdaq, subject to deferral until consummation of our initial business combination. Any such unpaid
amount will accrue without interest and be due and payable no later than the date of the consummation of initial business combination.
Upon completion of our initial business combination or our liquidation, we will cease paying.
General
No compensation or fees of
any kind, including finder’s fees, consulting fees, or other similar compensation, will be paid to our insiders or any of the members
of our management team, for services rendered to us prior to, or in connection with the consummation of our initial business combination
(regardless of the type of transaction that it is). However, such individuals will receive reimbursement for any out-of-pocket expenses
incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing business due
diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations
of prospective target businesses to examine their operations. There is no limit on the amount of out-of-pocket expenses reimbursable by
us; provided, however, that to the extent such expenses exceed the available proceeds not deposited in the trust account and the interest
income earned on the amounts held in the trust account, such expenses would not be reimbursed by us unless we consummate an initial business
combination.
All ongoing and future transactions
between us and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable
to us than are available from unaffiliated third parties. Such transactions will require prior approval by our audit committee and a majority
of our uninterested independent directors, in either case who had access, at our expense, to our attorneys or independent legal counsel.
We will not enter into any such transaction unless our audit committee and a majority of our disinterested independent directors determine
that the terms of such transaction are no less favorable to us than those that would be available to us with respect to such a transaction
from unaffiliated third parties.
Related Party Policy
Our Code of Ethics requires
us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts of interests, except
under guidelines approved by the board of directors (or the audit committee). Related-party transactions are defined as transactions in
which (1) the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2) we or any of our subsidiaries
is a participant, and (3) any (a) executive officer, director or nominee for election as a director, (b) greater than 5% beneficial owner
of our shares of common stock, or (c) immediate family member, of the persons referred to in clauses (a) and (b), has or will have a direct
or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner of another entity).
A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult to perform his or her
work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family, receives improper
personal benefits as a result of his or her position.
We also require each of our
directors and executive officers to annually complete a directors’ and officers’ questionnaire that elicits information about
related party transactions.
Our audit committee, pursuant
to its written charter, will be responsible for reviewing and approving related-party transactions to the extent we enter into such transactions.
All ongoing and future transactions between us and any of our officers and directors or their respective affiliates will be on terms believed
by us to be no less favorable to us than are available from unaffiliated third parties. Such transactions will require prior approval
by our audit committee and a majority of our uninterested “independent” directors, or the members of our board who do not
have an interest in the transaction, in either case who had access, at our expense, to our attorneys or independent legal counsel. We
will not enter into any such transaction unless our audit committee and a majority of our disinterested “independent” directors
determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect to such
a transaction from unaffiliated third parties.
23
These procedures are intended
to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the
part of a director, employee or officer.
To further minimize potential
conflicts of interest, we have agreed not to consummate a business combination with an entity which is affiliated with any of our insiders
unless we obtain an opinion from an independent investment banking firm that the business combination is fair to our unaffiliated stockholders
from a financial point of view. Furthermore, in no event will any of our existing officers, directors or insiders, or any entity with
which they are affiliated, be paid any finder’s fee, consulting fee or other compensation prior to, or for any services they render
in order to effectuate, the consummation of a business combination.
Director Independence
Nasdaq listing standards
require that a majority of our board of directors be independent. For a description of the director independence, see “ Part III,
Item 10 - Directors, Executive Officers and Corporate Governance” .
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
The firm of Friedman LLP,
or Friedman, acted as our independent registered public accounting firm from March 16, 2021 (inception) until October 11, 2022. Based
on information provided by Friedman, effective September 1, 2022, Friedman combined with Marcum LLP, or Marcum, and continued to operate
as an independent registered public accounting firm. Friedman continued to serve as our independent registered public accounting firm
through October 11, 2022. On October 11, 2022, our audit committee dismissed Friedman and engaged Marcum to serve as our independent registered
public accounting firm for the year ended December 31, 2022, effective immediately. The following is a summary of fees paid to Friedman
and Marcum for services rendered.
Audit Fees . For the
year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021, fees for Friedman were approximately
$75,000 and $0, respectively, for the services Friedman performed in connection with our Initial Public Offering and the audit of our
financial for the period from January 1, 2022 to January 10, 2022 and for the period from March 16, 2021 (inception) through December
31, 2021, and two interim reviews. For the year ended December 31, 2022, fees for Marcum were approximately $35,750 ($25,750 for the audit,
and $10,000 for the review), for the services Marcum performed in connection with the audit of our December 31, 2022 financial statements
included in this Annual Report on Form 10-K and one review.
Audit-Related Fees.
For the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021, our independent registered
public accounting firms did not render assurance and related services related to the performance of the audit or review of financial statements.
Tax Fees. For the
year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021, our independent registered
public accounting firms did not render assurance and related services related to the performance of the audit or review of our financial
statements.
All Other Fees . For
the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021, there were no fees billed
for products and services provided by our independent registered public accounting firms other than those set forth above.
Pre-Approval Policy
Our audit committee was formed
upon the consummation of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services,
although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation
of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted
non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions
for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
24
part
IV
ITEM 15 . EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following documents are filed as part of this Annual Report
on Form 10-K:
(1) Financial Statements:
Page
Report of Independent Registered Public Accounting Firm
F-2
Balance Sheets
F-4
Statements of Operations
F-5
Statements of Changes in Stockholders’ Deficit
F-6
Statements of Cash Flows
F-7
Notes to Financial Statements
F-8
(2) Financial Statement Schedules:
None.
(3) Exhibits
The following exhibits are
filed with this report. Exhibits which are incorporated herein by reference can be obtained from the SEC’s website at sec.gov.
Exhibit No.
Description
1.1
Underwriting Agreement, dated March 30, 2022, by and between the Company and Chardan Capital Markets, LLC (incorporated by reference to Exhibit 1.1 filed with Form 8-K filed by the Registrant on April 4, 2022).
3.1
Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with Form 8-K filed by the Registrant on April 4, 2022).
3.2
Certificate of Amendment, dated April 4, 2023, to Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with Form 8-K filed by the Registrant on April 4, 2023).
3.3
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.5 filed with Form S-1 filed by the Registrant on March 10, 2022).
4.1
Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 filed with Form S-1/A filed by the Registrant on March 25, 2022).
4.2
Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.2 filed with Form S-1 filed by the Registrant on March 10, 2022).
4.3
Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 filed with Form S-1/A filed by the Registrant on March 25, 2022).
4.4
Specimen Rights Certificate (incorporated by reference to Exhibit 4.4 filed with Form S-1/A filed by the Registrant on March 25, 2022).
4.5
Warrant Agreement, dated March 30, 2022, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 filed with Form 8-K filed by the Registrant on April 4, 2022).
4.6
Rights Agreement, dated March 30, 2022, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.2 filed with Form 8-K filed by the Registrant on April 4, 2022).
4.7
Unit Purchase Option, dated April 4, 2022, issued by the Company to Chardan Capital Markets, LLC (incorporated by reference to Exhibit 4.3 filed with Form 8-K filed by the Registrant on April 4, 2022).
4.8*
Description of Securities
25
10.1
Letter Agreements, dated March 30, 2022, by and between the Company and each of the Company’s officers, directors and initial stockholders (incorporated by reference to Exhibit 10.1 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.2
Investment Management Trust Agreement, dated March 30, 2022, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.2 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.3
Stock Escrow Agreement, dated March 30, 2022, by and among the Company, Continental Stock Transfer & Trust Company and the initial stockholders of the Company (incorporated by reference to Exhibit 10.3 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.4
Registration Rights Agreement, dated March 30, 2022, by and among the Company, the initial stockholders of the Company and Chardan Capital Markets, LLC (incorporated by reference to Exhibit 10.4 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.5
Subscription Agreement, dated March 30, 2022, by and between the Company and Redwoods Capital LLC (incorporated by reference to Exhibit 10.5 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.6
Subscription Agreement, dated March 30, 2022, by and between the Company and Chardan Capital Markets, LLC (incorporated by reference to Exhibit 10.6 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.7
Indemnity Agreements, dated March 30, 2022, by and between the Company and each of the directors and officers of the Company (incorporated by reference to Exhibit 10.7 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.8
Administrative Support Agreement, dated March 30, 2022, by and between the Company and Redwoods Capital LLC (incorporated by reference to Exhibit 10.8 filed with Form 8-K filed by the Registrant on April 4, 2022).
10.9
Promissory Note to Redwoods Capital LLC, dated March 22, 2023 (incorporated by reference to Exhibit 10.1 filed with Form 8-K filed by the Registrant on March 28, 2023).
10.10
Promissory Note to Redwoods Capital LLC, dated March 30, 2023 (incorporated by reference to Exhibit 10.2 filed with Form 8-K filed by the Registrant on April 4, 2023).
10.11
Amendment to the Investment Management Trust Agreement, dated April 4, 2023, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.1 filed with Form 8-K filed by the Registrant on April 4, 2023).
14
Code of Ethics (incorporated by reference to Exhibit 14 filed with Form S-1 filed by the Registrant on March 10, 2022)
21.1*
List of Subsidiaries
31.1*
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**
Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*
Inline XBRL Instance Document - the instance document does not appear
in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*
Inline XBRL Taxonomy Extension Schema Document.
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase
Document.
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase
Document.
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase
Document.
104*
Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
* Filed herewith.
** Furnished herewith. This certification is being furnished solely
to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Exchange Act of
1934, as amended, and is not to be incorporated by reference into any filings of the Registrant, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.
ITEM 16 . FORM 10-K SUMMARY
Not applicable.
26
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Dated: April 10, 2023
REDWOODS ACQUISITION CORP.
By:
/s/ Jiande Chen
Name:
Jiande Chen
Title:
Chief Executive Officer
Pursuant to the requirements
of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.
Signature
Title
Date
/s/ Jiande Chen
Chief Executive Officer and Director
April 10, 2023
Jiande Chen
(Principal Executive Officer)
/s/ Edward Cong Wang
Chief Financial Officer and Director
April 10, 2023
Edward Cong Wang
(Principal Accounting and Financial Officer)
/s/ Raymond J. Gibbs
Director
April 10, 2023
Raymond J. Gibbs
/s/ Wei Kwang Ng
Director
April 10, 2023
Wei Kwang Ng
/s/ Hong Li
Director
April 10, 2023
Hong Li
27
REDWOODS
ACQUISITION CORP
INDEX
TO FINANCIAL STATEMENTS
Page
Report of Independent Registered Public Accounting Firm – Marcum LLP (PCAOB ID 688) F-2
Report of Independent Registered Public Accounting Firm – Friedman LLP (PCAOB ID 711 ) F-3
Balance Sheets as of December 31, 2022 and December 31, 2021 F-4
Statements of Operations for the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021 F-5
Statements of Changes in Stockholders’ Deficit for the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021 F-6
Statements of Cash Flows for the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021 F-7
Notes to Financial Statements F-8
F- 1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
Redwoods Acquisition Corporation
Opinion on the Financial Statements
We have audited the accompanying balance sheet
of Redwoods Acquisition Corporation (the “Company”) as of December 31, 2022, the related statements of operations, stockholders’
deficit and cash flows for year ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2022, and the results of its operations and its cash flows for the year ended December 31, 2022, in conformity with accounting principles
generally accepted in the United States of America.
Explanatory Paragraph – Going Concern
The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements,
the Company’s business plan is dependent on the completion of a business combination and the Company’s cash and working capital
as of December 31, 2022 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to
be one year from the issuance date of the financial. These conditions raise substantial doubt about the Company’s ability to continue
as a going concern. Management’s plans in regard to these matters are also described in Note 1 . The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provide s a reasonable basis for our opinion.
/s/ Marcum llp
Marcum llp
We have served as the Company’s auditor since 2021 (such date
takes into account the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1, 2022)
East Hanover, NJ
April 10, 2023
F- 2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholder of
Redwoods Acquisition Corp.
Opinion on the Financial Statements
We have audited the accompanying balance sheet
of Redwoods Acquisition Corp. (the “Company”) as of December 31, 2021, the related statements of operations, changes in stockholder’s
equity and cash flows for the period from March 16, 2021 (inception) through December 31, 2021, and the related notes (collectively referred
to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the
financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the period from March
16, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.
Explanatory Paragraph — Going Concern
The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, its business
plan is dependent on the completion of a financing and the Company’s cash and working capital as of December 31, 2021 are not sufficient
to complete its planned activities. These conditions raise substantial doubt about the Company’s ability to continue as a going
concern. Management’s plans in regard to these matters are also described in Notes 1 and 3. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Friedman LLP
Friedman LLP
We have served as the Company’s auditor
from 2021 through 2022.
New York, NY
January 31, 2022
F- 3
REDWOODS
ACQUISITION CORP.
BALANCE SHEETS
December 31,
2022
December 31,
2021
Assets
Current Assets
Cash
$ 340,962
$ 4,952
Prepaid expenses
99,196
—
Total Current Assets
440,158
4,952
Investments held in Trust Account
117,806,478
—
Total Assets
$ 118,246,636
$ 4,952
Liabilities, Temporary Equity, and Stockholders’ Deficit
Current Liabilities
Accrued expenses
$ 140,370
$ —
Franchise tax payable
122,801
—
Income tax payable
243,070
—
Due to related party
—
8,511
Total Current Liabilities
506,241
8,511
Warrant liability
31,800
—
Deferred tax liability
78,955
—
Deferred underwriting fee payable
4,312,500
—
Total Liabilities
4,929,496
8,511
Commitments and Contingencies
Common stock subject to possible redemption, 11,500,000 shares at conversion value of $ 10.21 per share
117,361,652
—
Stockholders’ Deficit
Common stock, $ 0.0001 par value; 50,000,000 shares authorized; 3,405,000 and 0 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively
340
—
Additional paid-in capital
—
—
Accumulated deficit
( 4,044,852 )
( 3,559 )
Total Stockholders’ Deficit
( 4,044,512 )
( 3,559 )
Total Liabilities, Temporary Equity, and Stockholders’ Deficit
$ 118,246,636
$ 4,952
The
accompanying notes are an integral part of these financial statements.
F- 4
REDWOODS
ACQUISITION CORP.
STATEMENTS OF OPERATIONS
For the year
ended
December 31,
For the
period from
March 16,
2021
(inception)
through
December 31,
2022
2021
General and administrative expenses
$ 533,992
$ 3,559
Franchise tax expenses
123,026
—
Loss from operations
( 657,018 )
( 3,559 )
Interest earned on investment held in Trust Account
1,280,500
—
Unrealized gain on investment held in Trust Account
375,978
Change in fair value of warrant liabilities
555,917
—
Income (loss) before income taxes
1,555,377
( 3,559 )
Deferred income taxes provision
( 78,955 )
—
Income taxes provision
( 243,070 )
—
Net income (loss)
$ 1,233,352
$ ( 3,559 )
Basic and diluted weighted average shares outstanding, redeemable common stock
8,526,027
—
Basic and diluted net income per share, redeemable common stock
1.05
—
Basic and diluted weighted average shares outstanding, non-redeemable common stock
3,236,568
—
Basic and diluted net loss per share, non-redeemable common stock
$ ( 2.39 )
$ —
The
accompanying notes are an integral part of these financial statements.
F- 5
REDWOODS
ACQUISITION CORP.
STATEMENTS OF CHANGES IN STOCKHOLDERS’DEFICIT
For
the Year Ended December 31, 2022
Common stock
Additional
Paid-in
Accumulated
Total
Stockholders’
Shares
Amount
Capital
Deficit
Deficit
Balance, January 1, 2022
—
$ —
$ —
$ ( 3,559 )
$ ( 3,559 )
Common stock issued to initial stockholders
2,875,000
287
24,713
$ —
25,000
Sale of public units in initial public offering
11,500,000
1,150
114,998,850
—
115,000,000
Sale of private placement units
530,000
53
5,299,947
—
5,300,000
Sale of unit purchase option to underwriter
—
—
100
—
100
Underwriter commissions
—
—
( 7,187,500 )
—
( 7,187,500 )
Offering costs
—
—
( 462,536 )
—
( 462,536 )
Warrant Liabilities
—
—
( 587,717 )
—
( 587,717 )
Reclassification of common stock subject to redemption
( 11,500,000 )
( 1,150 )
( 94,873,850 )
—
( 94,875,000 )
Allocation of offering costs to common stock subject to redemption
—
—
6,901,405
—
6,901,405
Accretion of common stock to redemption value
—
—
( 24,113,412 )
( 5,274,645 )
( 29,388,057 )
Net income for the year
—
—
—
1,233,352
1,233,352
Balance as of December 31, 2022
3,405,000
$ 340
$ —
$ ( 4,044,852 )
$ ( 4,044,512 )
For
the period from March 16, 2021 (inception) through December 31, 2021
Common Stock
Additional
Paid-In
Accumulated
Total
Stockholder’s
Shares
Amount
Capital
Deficit
Deficit
Balance as of March 16, 2021 (inception)
—
$ —
$ —
$ —
$ —
Net loss
—
—
—
( 3,559 )
( 3,559 )
Balance as of December 31, 2021
—
$ —
$ —
$ ( 3,559 )
$ ( 3,559 )
The
accompanying notes are an integral part of these financial statements.
F- 6
REDWOODS
ACQUISITION CORP.
STATEMENTS OF CASH FLOWS
For the year
ended
December 31,
2022
For the
period from
March 16, 2021
(inception)
through
December 31,
2021
Cash flows from operating activities:
Net Income (loss)
$ 1,233,352
$ ( 3,559 )
Adjustments to reconcile net cash used in operating activities:
Interest earned on investment held in Trust Account
( 1,656,478 )
—
Change in fair value of warrant liabilities
( 555,917 )
—
Changes in current assets and current liabilities:
Prepaid expenses
( 99,196 )
—
Accrued expenses
140,370
—
Franchise tax payable
122,801
—
Income tax payable
243,070
—
Deferred income tax liability
78,955
—
Formation costs paid by related party
—
8,511
Net cash used in operating activities
( 493,043 )
4,952
Cash Flows from Investing Activities:
Purchase of investment held in Trust Account
( 116,150,000 )
—
Net cash used in financing activities
( 116,150,000 )
—
Cash Flows from Financing Activities:
Proceeds from issuance of insider shares to the initial stockholders
25,000
—
Proceeds from sale of public units through public offering
115,000,000
—
Proceeds from sale of private placement units
5,300,000
—
Proceeds from sale of unit purchase option
100
—
Proceeds from issuance of promissory note to related party
200,000
Repayment of promissory note to related party
( 200,000 )
—
Repayment of advance from related party
( 8,511 )
—
Payment of underwriters’ commissions
( 2,875,000 )
—
Payment of deferred offering costs
( 462,536 )
—
Net cash provided by financing activities
116,979,053
—
Net change in cash
336,010
4,952
Cash, beginning of the period
4,952
—
Cash, end of the period
$ 340,962
$ 4,952
Supplemental Disclosure of Non-cash Financing Activities
Initial classification of common stock subject to redemption
$ 94,873,850
$ —
Initial recognition of warrant liabilities
$ 587,717
$ —
Deferred underwriting fee payable
$ 4,312,500
$ —
Allocation of offering costs to common stock subject to redemption
$ 6,901,405
$ —
Accretion of Common stock to redemption value
$ 29,388,057
$ —
The
accompanying notes are an integral part of these financial statements.
F- 7
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Note
1 — Description of Organization and Business Operations
Redwoods
Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated as a Delaware corporation on March
16, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited
to a particular industry or geographic region for purposes of consummating a Business Combination.
As
of December 31, 2022, the Company had not commenced any operations. All activities through December 31, 2022 are related to the Company’s
formation, the initial public offering (“IPO” as defined below in Note 4) and, subsequent to the IPO, identifying a target
company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination,
at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO.
The Company has selected December 31 as its fiscal year end.
The
Company’s sponsor is Redwoods Capital LLC, a Delaware limited liability company (the “Sponsor”).
The
registration statement for the Company’s IPO became effective on March 30, 2022. On April 4, 2022, the Company consummated the
IPO of 10,000,000 units at an offering price of $ 10.00 per unit (the “Public Units’), generating gross proceeds of $ 100,000,000 .
Simultaneously with the closing of the IPO, the Company sold to the Sponsor and Chardan Capital Markets LLC (“Chardan”),
in a private placement, 377,500 units and 100,000 units, respectively, at $ 10.00 per unit (the “Private Units”), generating
total gross proceeds of $ 4,775,000 , which is described in Note 5.
The
Company granted the underwriters a 45-day option to purchase up to 1,500,000 additional Public Units to cover over-allotments, if any.
On April 7, 2022, the underwriters exercised the over-allotment option in full and purchased 1,500,000 Public Units at a price of $ 10.00
per Public Unit, generating gross proceeds of $ 15,000,000 . Simultaneously with the closing of the over-allotment option, the Company
consummated the sale of an additional aggregate of 52,500 Private Units with the Sponsor and Chardan at a price of $ 10.00 per Private
Unit, generating total proceeds of $ 525,000 .
Transaction
costs amounted to $ 8,365,339 , consisting $ 2,875,000 of underwriting fees, $ 4,312,500 of deferred underwriting fees (payable only upon
completion of a Business Combination) and $ 1,177,839 of other offering costs.
Upon
the closing of the IPO and the sale of Private Units on April 4, 2022, and the exercise of the over-allotment option and the sale of
the additional Private Units on April 7, 2022, a total of $ 116,150,000 was placed in a trust account (the “Trust Account”)
maintained by Continental Stock Transfer & Trust Company as a trustee and will be invested only in U.S. government securities with
a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of
1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations. The
funds in the Trust Account will not be released until the earlier of the completion of the initial Business Combination and the liquidation
due to the Company’s failure to complete a Business Combination within the applicable period of time. The proceeds deposited in
the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims
of the Company’s public stockholders. In addition, interest income earned on the funds in the Trust Account may be released to
the Company to pay its income or other tax obligations. With these exceptions, expenses incurred by the Company may be paid prior to
a Business Combination only from the net proceeds of the IPO and private placement not held in the Trust Account.
Pursuant
to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate
fair market value equal to at least 80% of the value of the funds in the Trust Account (excluding any deferred underwriting discounts
and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time
of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination
with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is
no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if
the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a
controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company
Act.
F- 8
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders
will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated
to be $ 10.10 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to
the Company to pay its franchise and income tax obligations).
If
a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons,
the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and
file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction
is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem
shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally,
each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor and any of the Company’s
officers or directors that may hold Insider Shares (as defined in Note 6) (the “Initial Stockholders”) and Chardan have
agreed (a) to vote their Insider Shares, the shares underlying the Private Units (“Private Shares”) and any Public Shares
purchased during or after the IPO in favor of approving a Business Combination, to the extent permitted by law, and (b) not to convert
any shares (including the Insider Shares) in connection with a stockholder vote to approve, or sell the shares to the Company in any
tender offer in connection with, a proposed Business Combination.
The
Initial Stockholders and Chardan have agreed (a) to waive their redemption rights with respect to the Insider Shares, Private Shares
and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of,
an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s
obligation to redeem 100 % of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the
Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The Company has until July 4, 2023 to consummate
a Business Combination. In addition, if the Company anticipates that it may not be able to consummate a Business Combination by such date,
the Sponsor or its affiliates may extend the period of time to consummate a Business Combination five times by an additional one month
each time (for a total of 20 months to complete a Business Combination) (the “Combination Period”). In order to extend the
time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees, within two business days
prior to the applicable deadline, must deposit into the Trust Account $120,000 for each subsequent one-month extension.
If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest
(which interest shall be net of taxes payable, and less certain amount of interest to pay dissolution expenses) divided by the number
of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board
of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law.
F- 9
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
Initial Stockholders and Chardan have agreed to waive their liquidation rights with respect to the Insider Shares and Private Shares,
as applicable, if the Company fails to complete a Business Combination within the Combination Period. However, if any Initial Stockholder
or Chardan acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust
Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive
their rights to their deferred underwriting commissions (see Note 7) held in the Trust Account in the event the Company does not complete
a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in
the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible
that the per share value of the assets remaining available for distribution will be less than $ 10.10 .
In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold
to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality
or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $ 10.10
per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust
Account, if less than $ 10.10 per share due to reductions in the value of the trust assets, in each case less taxes payable, provided
that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all
rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the
Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act
of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims.
Liquidity,
Capital Resources and Going Concern
As of December 31, 2022, the Company had cash
of $ 340,962 and a working capital of $ 299,788 (excluding income tax and franchise tax payable as the taxes will be paid out of the Trust
Account). On March 22 and March 30, 2023, the Sponsor provided a loan of up to $ 150,000 and $ 360,000 , respectively, to be used, in part,
for transaction costs related to the Business Combination (see Note 6). The Company has until July 4, 2023 (or December 4, 2023, if the
time to complete a business combination is extended as described herein) to consummate a Business Combination. It is uncertain that the
Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there
will be a mandatory liquidation and subsequent dissolution.
The
Company expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction
costs in pursuit of the consummation of a Business Combination. The Company may need to obtain additional financing either to complete
its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business
Combination, in which case the Company may issue additional securities or incur debt in connection with such Business Combination. Subject
to compliance with applicable securities laws, the Company would only complete such financing simultaneously with the completion of our
Business Combination. If the Company is unable to complete its Business Combination because it does not have sufficient funds available,
it will be forced to cease operations and liquidate the Trust Account. In addition, following the Business Combination, if cash on hand
is insufficient, the Company may need to obtain additional financing in order to meet its obligations.
In connection with the Company’s assessment
of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, the Company has until
April 4, 2023 (or October 4, 2023, if the Company extends the time to complete a Business Combination) to complete a Business Combination.
It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated
by such date and an extension has not been requested by the Sponsor and approved by the Company’s stockholders, there will be a
mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition, the mandatory
liquidation, should a Business Combination not occur and an extension not be requested by the Sponsor, and potential subsequent dissolution
raise substantial doubt about the Company’s ability to continue as a going concern. The financial statement does not include any
adjustments that might result from the outcome of this uncertainty.
F- 10
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Risks
and Uncertainties
Management
is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
the virus could have a negative effect on the Company’s future financial position, results of its operations and/or search for
a target company, there has not been a significant impact as of the date of these financial statements. The financial statements do not
include any adjustments that might result from the future outcome of this uncertainty.
Additionally,
as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related
economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which
the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s
ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these
events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable
on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact
on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable.
The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Inflation
Reduction Act of 2022
On
August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for,
among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic
(i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the
repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1%
of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax,
repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of
stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury
(the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or
avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.
Any
redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise,
may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business
Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions
and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii)
the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued
not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content
of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the
redeeming holders, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction
in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
At
this time, it has been determined that none of the IR Act tax provisions have an impact to the Company’s fiscal 2022 tax provision.
The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act
to determine whether any adjustments are needed to the Company’s tax provision in future periods.
Note
2 — Significant Accounting Policies
Basis
of Presentation
The
accompanying audited financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted
in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they include
all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals)
considered for a fair presentation have been included.
F- 11
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use
of Estimates
In
preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $ 340,962 and $ 4,952 in cash and did not have any cash equivalents as of December 31, 2022 and December 31, 2021, respectively.
Investments
Held in Trust Account
As
of December 31, 2022, the assets held in the Trust Account were held in cash and U.S. Treasury securities. The Company classifies its
U.S. Treasury securities as trading securities in accordance with Financial Accounting Standards Board (“FASB”) Accounting
Standards Codification (“ASC”) Topic 320, “Investments—Debt and Equity Securities.” Trading securities
are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in
fair value of these securities is included in gain on investments held in Trust Account in the accompanying statement of operations.
The estimated fair values of all assets held in the Trust Account are determined using available market information and classified as
Level 1 measurements.
F- 12
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Offering
Costs
The
Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials”
(“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs were $ 8,365,339
consisting principally of underwriting, legal, accounting and other expenses that are directly related to the IPO and charged to stockholders’
equity upon the completion of the IPO.
Income
Taxes
The
Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.
The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently
not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The
Company has identified the United States and the State of New York as its only “major” tax jurisdiction. The Company is subject
to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions,
the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net
Loss Per Share
The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income
per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company
first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed
income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss)
ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement
of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public
shareholders. As of December 31, 2022, the Company did not have any dilutive securities and other contracts that could, potentially,
be exercised or converted into common shares and then share in the earnings of the Company. As a result, diluted loss per share is the
same as basic loss per share for the period presented.
F- 13
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
net income (loss) per share presented in the statement of operations is based on the following:
For the Year Ended December 31, 2022
For the
Period from
March 16, 2021
(Inception) through
December 31, 2021
Net Income
$ 1,233,352
$ ( 3,559 )
Accretion of common stock to redemption value
( 29,388,057 )
—
Net loss including accretion of common stock to redemption value
$ ( 28,154,705 )
$ ( 3,559 )
For the
Period from
March 16, 2021
(Inception)
For the Year Ended
through
December 31, 2022
December 31, 2021
Redeemable
shares
Non-
redeemable
shares
Redeemable
shares
Non-
redeemable
shares
Basic and diluted net income (loss) per common stock
Numerator:
Allocation of net loss
$ ( 20,407,722 )
$ ( 7,746,983 )
$ —
$ ( 3,559 )
Accretion of ordinary shares subject to possible redemption to redemption value
29,388,057
—
—
—
Allocation of net income (loss)
$ 8,980,335
$ ( 7,746,983 )
$ —
$ ( 3,559 )
Denominator:
Basic and diluted weighted average shares outstanding
8,526,027
3,236,568
—
—
Basic and diluted net income (loss) per common stock
$ 1.05
$ ( 2.39 )
$ —
$ —
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
and money market funds held in the Trust Account. The Company has not experienced losses on this account and management believes the
Company is not exposed to significant risks on such account.
Fair
Value of Financial Instruments
FASB
ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the
expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation
techniques consistent with the market approach, income approach and cost approach shall be used to measure fair value. FASB ASC Topic
820 establishes a fair value hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset
or liability. These inputs are further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller
would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs
reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed
based on the best information available in the circumstances.
F- 14
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
fair value hierarchy is categorized into three levels based on the inputs as follows:
Level 1 —
Valuations
based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and
regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.
Level 2 —
Valuations
based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active
for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived
principally from or corroborated by market through correlation or other means.
Level 3 —
Valuations
based on inputs that are unobservable and significant to the overall fair value measurement.
The
fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair
Value Measurements and Disclosures,” approximates the carrying amounts represented in the consolidated balance sheet. The fair
values of cash and cash equivalents, and other current assets, accrued expenses, due to sponsor are estimated to approximate the carrying
values as of December 31, 2022 and December 31, 2021 due to the short maturities of such instruments. See Note 9 for the disclosure
of the Company’s assets and liabilities that were measured at fair value on a recurring basis.
Warrants
The
Company accounts for warrants (Public Warrants or Private Warrants) as either equity-classified or liability-classified instruments based
on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board
(“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”)
and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants
meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s
own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside
of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional
judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance.
For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded
as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Company accounts for its Public
Warrants as equity and the Private Warrants as liabilities.
Common
Stock Subject to Possible Redemption
The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing
Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and are
measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control)
is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s
common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence
of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value
of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying
amount of shares of redeemable common stock are affected by charges against additional paid in capital or accumulated deficit if
additional paid in capital equals to zero.
F- 15
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Recent
Accounting Pronouncements
In
August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s
Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2024 for the Company and should be applied on a full or modified
retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact,
if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.
Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on the Company’s financial statements.
Note
3 — Cash and Investment Held in Trust Account
As of December 31, 2022, investment securities
in the Company’s Trust Account consisted of $ 117,806,478 cash and U.S. Treasury securities. The Company did not have a Trust Account
at December 31, 2021.
The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December
31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
December 31,
2022
Quoted
Prices in
Active
Markets (Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Other
Unobservable
Inputs
(Level 3)
Assets
Marketable securities held in trust account
$ 117,806,478
$ 117,806,478
—
—
Note
4 — Initial Public Offering
On
April 4, 2022, pursuant to its initial public offering (the “IPO”), the Company sold 10,000,000 Public Units at $ 10.00 per
Public Unit, generating gross proceeds of $ 100,000,000 . The Company granted the underwriters a 45-day option to purchase up to 1,500,000
additional Public Units to cover over-allotments, if any. On April 7, 2022, the underwriters exercised the over-allotment option in full
and purchased 1,500,000 Public Units at a price of $ 10.00 per Public Unit, generating gross proceeds of $ 15,000,000 . Each Public Unit
consists of one share of common stock (“Public Share”), one right (“Public Right”) and one redeemable warrant
(“Public Warrant”). Each Public Right will convert into one-tenth (1/10) of one share of common stock upon the consummation
of a Business Combination. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $ 11.50 per share,
subject to adjustment. The Public Warrants will become exercisable on the later of the completion of the Company’s initial Business
Combination or 12 months from the closing of the IPO, and will expire five years after the completion of the Company’s initial
Business Combination or earlier upon redemption or liquidation.
All
of the 11,500,000 Public Shares sold as part of the Public Units in the IPO contain a redemption feature which allows for the
redemption of such Public Shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection
with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s
liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC
480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified
outside of permanent equity.
F- 16
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
Company’s redeemable common stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has
been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either
accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the
instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption
value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend
(i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).
As
of December 31, 2022, the shares of common stock reflected on the balance sheet are reconciled in the following table.
As of
December 31, 2022
Gross proceeds
$ 115,000,000
Less:
Proceeds allocated to Public Warrants
( 10,695,000 )
Proceeds allocated to Public Rights
( 9,430,000 )
Offering costs of Public Shares
( 6,901,405 )
Plus:
Accretion of carrying value to redemption value
29,388,057
Class A Common stock subject to possible redemption
$ 117,361,652
Note
5 — Private Placement
Simultaneously
with the closing of the IPO, the Sponsor and Chardan purchased an aggregate of 477,500 Private Units at a price of $ 10.00 per Private
Unit for an aggregate purchase price of $ 4,775,000 in a private placement. Simultaneously with the closing of the over-allotment option,
the Company consummated the sale of an additional aggregate of 52,500 Private Units with the Sponsor and Chardan at a price of $ 10.00
per Private Unit, generating total proceeds of $ 525,000 . The Private Units are identical to the Public Units except with respect to certain
registration rights and transfer restrictions and the private warrants, which have terms and provisions that are identical to those of
the warrants being sold as part of the units in the IPO, except that the private warrants (i) will be exercisable either for cash or
on a cashless basis at the holder’s option and (ii) will not be redeemable by the Company, in either case as long as the private
warrants are held by the initial purchasers or any of their permitted transferees. The net proceeds from the Private Units were added
to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination
Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements
of applicable law), and the Private Units and all underlying securities will expire worthless.
Note
6 — Related Party Transactions
Insider
Shares
On
January 4, 2022, the Company issued 2,875,000 shares of common stock (the “Insider Shares”) to the Initial Stockholders for
an aggregate consideration of $ 25,000 , or approximately $ 0.009 per share. As a result of the underwriters’ full exercise of their
over-allotment option on April 7, 2022, no insider shares are currently subject to forfeiture. As of December 31, 2022, there were 2,875,000
Insider Shares issued and outstanding.
The
Initial Stockholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Insider Shares
until, with respect to 50% of the Insider Shares, the earlier of six months after the consummation of a Business Combination and
the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a
Business Combination and, with respect to the remaining 50% of the Insider Shares, until the six months after the consummation of
a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger,
stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their
shares of common stock for cash, securities or other property.
F- 17
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Promissory
Note — Related Party
On January 4, 2022 and February 28, 2022, the
Sponsor agreed to loan the Company up to an aggregate amount of $ 200,000 to be used, in part, for transaction costs incurred in connection
with the IPO (the “Promissory Notes”). The Promissory Notes were unsecured, interest-free and due on the closing the IPO.
The Company repaid the outstanding balance of $ 200,000 to the Sponsor on April 7 and April 8, 2022. As of December 31, 2022, the Company
had no borrowings under the Promissory Note.
On March 22 and March 30, 2023, the Sponsor provided
a loan of up to $ 150,000 and $ 360,000 , respectively, to be used, in part, for transaction costs related to the Business Combination.
Related
Party Loans
In
addition, in order to finance transaction costs in connection with searching for a target business or consummating an intended initial
business combination, the initial stockholders, officers, directors or their affiliates may, but are not obligated to, loan us funds
as may be required. In the event that the initial business combination does not close, the Company may use a portion of the working capital
held outside the trust account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment.
Such loans would be evidenced by promissory notes. The notes would either be paid upon consummation of our initial business combination,
without interest, or, at the lender’s discretion, up to $ 500,000 of the notes may be converted upon consummation of the Company’s
business combination into private units at a price of $ 10.00 per unit. The purchase price of these units will approximate the fair value
of such units when issued. However, if it is determined, at the time of issuance, that the fair value of such units exceeds the purchase
price, the Company would record compensation expense for the excess of the fair value of the units on the day of issuance over the
purchase price in accordance with Accounting Standards Codification (“ASC”) 718 - Compensation - Stock Compensation.
As
of December 31, 2022, the Company had no borrowings under the working capital loans.
Administrative
Services Agreement
The
Company entered into an agreement, commencing on the effective date of the IPO through the earlier of the Company’s consummation
of a Business Combination and its liquidation, to pay the Sponsor a total of $ 10,000 per month for office space, utilities, secretarial
and administrative support. However, pursuant to the terms of such agreement, the Sponsor agreed to defer the payment of such monthly
fee. Any such unpaid amount will accrue without interest and be due and payable no later than the date of the consummation of initial
Business Combination. For the year ended December 31, 2022 and for the period from March 16, 2021 (inception) through December 31, 2021,
the Company incurred $ 90,000 and none , respectively, in fees for these services, of which $ 90,000 and none were included in accrued expenses
in the accompanying balance sheets as of December 31, 2022 and December 31, 2021, respectively.
Note 7 — Commitments
and Contingencies
Registration
Rights
The
holders of the insider shares, the private units, securities underlying the Unit Purchase Option and any units that may be issued upon
conversion of working capital loans or extension loans (and any securities underlying the private units or units issued upon conversion
of the working capital loans or extension loans) will be entitled to registration rights pursuant to a registration rights agreement
signed on the effective date of the IPO. The holders of a majority of these securities are entitled to make up to two demands (or one
demand with respect to the securities underlying the Unit Purchase Option) that the Company register such securities. The holders of
the majority of the Insider Shares can elect to exercise these registration rights at any time commencing three months prior to the date
on which these shares of common stock are to be released from escrow. The holders of a majority of the private units and units issued
in payment of working capital loans made to us can elect to exercise these registration rights at any time commencing on the date that
the Company consummate an initial business combination. In addition, the holders have certain “piggy-back” registration rights
with respect to registration statements filed subsequent to the consummation of an initial business combination. Furthermore, notwithstanding
the foregoing, pursuant to FINRA Rule 5110, Chardan may not exercise its demand and “piggyback” registration rights after
five and seven years, respectively, after the commencement of sales of this offering and may not exercise its demand rights on more than
one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
F- 18
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Underwriting
Agreement
Pursuant
to an underwriting agreement in connection with the IPO, the Company granted Chardan, the representative of the underwriters, a 45-day
option from the date of the prospectus for the IPO to purchase up to 1,500,000 additional Public Units to cover over-allotments,
if any, at the IPO price less the underwriting discounts and commissions. On April 7, 2022, Chardan exercised the over-allotment option
in full (see Note 4).
The
underwriters were paid a cash underwriting discount of 2.5 % of the gross proceeds of the IPO (including the exercise of the over-allotment
option), or $ 2,875,000 . In addition, the underwriters will be entitled to a deferred fee of 3.75 % of the gross proceeds of the IPO (including
the exercise of the over-allotment option), or $ 4,312,500 , which will be paid upon the closing of a Business Combination from the amounts
held in the Trust Account, subject to the terms of the underwriting agreement.
Unit
Purchase Option
Simultaneously
with the IPO (including the closing of the over-allotment option), the Company sold to Chardan, for $ 100 , an option (the “Unit
Purchase Option”) to purchase 345,000 units exercisable at $ 11.50 per unit (or an aggregate exercise price of $ 3,967,500 ) commencing
on the later of six months from the effective date of the registration statement related to the IPO and the consummation of a Business
Combination. The fair value of the Unit Purchase Option was $ 715,303 at the IPO which was included in the total offering costs of $ 8,365,339 .
The Unit Purchase Option may be exercised for cash or on a cashless basis, at the holder’s option, and expires five years from
the effective date of the registration statement related to the IPO. The units issuable upon exercise of the Unit Purchase Option are
identical to those offered in the IPO. The Company accounts for the Unit Purchase Option, inclusive of the receipt of $ 100 cash payment,
as an expense of the IPO resulting in a charge directly to stockholders’ equity. The Unit Purchase Option and such units purchased
pursuant to the Unit Purchase Option, as well as the common stock underlying such units, the rights included in such units, the shares
of common stock that are issuable for the rights included in such units, the warrants included in such units, and the shares underlying
such warrants, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1).
The Unit Purchase Option grants to holders demand and “piggy back” rights for periods of five and seven years, respectively,
from the effective date of the registration statement with respect to the registration under the Securities Act of the securities
directly and indirectly issuable upon exercise of the Unit Purchase Option. The Company will bear all fees and expenses attendant to
registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price
and number of units issuable upon exercise of the Unit Purchase Option may be adjusted in certain circumstances including in the event
of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be
adjusted for issuances of common stock at a price below its exercise price.
Right
of First Refusal
The
Company has granted Chardan a right of first refusal, for a period of 18 months after the date of the consummation of a Business
Combination, to act as a book-running manager or placement agent, with at least 30% of the economics, for any and all future public and
private equity, equity linked and debt offerings of the Company or any of its successors or subsidiaries.
Note 8 — Stockholders’
Equity
Common
Stock — The Company is authorized to issue 50,000,000 shares of common stock with a par value of $ 0.0001 per
share. Holders of the common stock are entitled to one vote for each share. At December 31, 2022, there were 3,405,000 shares of common
stock issued and outstanding (excluding 11,500,000 shares subject to possible redemption).
F- 19
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Rights — Each
holder of a right will receive one-tenth (1/10) of one share of common stock upon consummation of a Business Combination, even if the
holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon
conversion of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional
shares upon consummation of a Business Combination, as the consideration related thereto has been included in the unit purchase price
paid for by investors in the IPO. If the Company enters into a definitive agreement for a Business Combination in which the Company will
not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration
the holders of the common stock will receive in the transaction on an as-converted into common stock basis and each holder of a right
will be required to affirmatively covert its rights in order to receive 1/10 share underlying each right (without paying additional consideration).
The shares issuable upon conversion of the rights will be freely tradable (except to the extent held by affiliates of the Company).
If
the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the
Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution
from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless.
Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business
Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, holders of the rights
might not receive the shares of common stock underlying the rights.
Warrants — Each
redeemable warrant entitles the holder thereof to purchase one share of common stock at a price of $ 11.50 per share, subject to adjustment.
The warrants will become exercisable on the later of the completion of an initial Business Combination and 12 months from the closing
of the IPO. However, no Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement
covering the issuance of the common stock issuable upon exercise of the warrants and a current prospectus relating to such common stock.
Notwithstanding the foregoing, if a registration statement covering the issuance of the common stock issuable upon exercise of the Public
Warrants is not effective within 90 days from the closing of the Company’s initial Business Combination, warrant holders may,
until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective
registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities
Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis. The
warrants will expire five years from the closing of the Company’s initial Business Combination at 5:00 p.m., New York
City time or earlier redemption.
In
addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in
connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than
$ 9.50 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the
aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for
the funding of the Company’s initial Business Combination, and (z) the volume weighted average trading price of the Company’s
common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
its initial Business Combination (such price, the “Market Price”) is below $ 9.50 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to 115 % of the Market Price, and the $ 16.50 per share redemption trigger price described
below will be adjusted (to the nearest cent) to be equal to 165 % of the Market Value.
The
Company may redeem the outstanding Public Warrants at any time while the warrants are exercisable:
● in whole and not in part;
● at a price of $ 0.01 per warrant;
● upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30-day redemption period;
● if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $ 16.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the to the warrant holders.
F- 20
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the
Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay
the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing
(x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise
price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market
value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading
day prior to the date on which the notice of redemption is sent to the holders of warrants.
Except
as described above, no warrants will be exercisable and the Company will not be obligated to issue common stock unless at the time a
holder seeks to exercise such warrant, a prospectus relating to the common stock issuable upon exercise of the warrants is current and
the common stock have been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the
holder of the warrants. Under the terms of the warrant agreement, the Company has agreed to use its best efforts to meet these conditions
and to maintain a current prospectus relating to the common stock issuable upon exercise of the warrants until the expiration of the
warrants. However, the Company cannot assure that it will be able to do so and, if the Company does not maintain a current prospectus
relating to the common stock issuable upon exercise of the warrants, holders will be unable to exercise their warrants and the Company
will not be required to settle any such warrant exercise. If the prospectus relating to the common stock issuable upon the exercise of
the warrants is not current or if the common stock is not qualified or exempt from qualification in the jurisdictions in which the holders
of the warrants reside, the Company will not be required to net cash settle or cash settle the warrant exercise, the warrants may have
no value, the market for the warrants may be limited and the warrants may expire worthless.
The
private warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in the IPO, except
that the private warrants (i) will be exercisable either for cash or on a cashless basis at the holder’s option and (ii) will not
be redeemable by the Company, in either case as long as the private warrants are held by the initial purchasers or any of their permitted
transferees.
Note
9 —Fair Value Measurements
The
fair value of the Company’s consolidated financial assets and liabilities reflects management’s estimate of amounts that
the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities
in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets
and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize
the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following
fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order
to value the assets and liabilities:
Level 1:
Quoted prices in active
markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the
asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2:
Observable inputs other
than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted
prices for identical assets or liabilities in markets that are not active.
Level 3:
Unobservable inputs based
on the assessment of the assumptions that market participants would use in pricing the asset or liability.
F- 21
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
The
following table presents information about the Company’s liabilities that are measured at fair value on December 31, 2022 and December
31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
December 31,
2022
Quoted
Prices in
Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Other
Unobservable
Inputs
(Level 3)
Liabilities:
Warrant liability
$ 31,800
—
—
$ 31,800
December 31, 2021
Quoted
Prices in
Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Other
Unobservable
Inputs
(Level 3)
Liabilities:
Warrant liability
$ —
—
—
$ —
The
private warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance
sheet. Changes in the fair value of the warrants are recorded in the statement of operations each period.
The
table below shows the change in fair value of warrant liabilities as of December 31, 2022:
Private
Warrants
Total
Fair value at January 1, 2022
$ –
$ –
Initial recognition
587,717
587,717
Change in fair value
( 555,917 )
( 555,917 )
Fair value as of December 31, 2022
$ 31,800
$ 31,800
The
Company established the initial fair value for the private warrants at $ 587,717 (including over-allotment) on April 4, 2022, the date
of the Company’s IPO, using the Black-Scholes model. The Company allocated the proceeds received from the sale of Private Units,
first to the private warrants based on their fair values as determined at initial measurement, with the remaining proceeds recorded as
common shares subject to possible redemption, and common shares based on their relative fair values recorded at the initial measurement
date. The warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.
The
key inputs into the Black-Scholes model were as follows at their measurement date:
December 31,
2022
April 4,
2022
(initial
measurement)
Exercise Price
$ 11.50
$ 11.50
Underlying share price
$ 10.06
$ 8.08
Expected Volatility
2.97 %
25.62 %
Warrant life (years)
5.0
5.0
Risk-free rate
3.99 %
2.42 %
F- 22
REDWOODS
ACQUISITION CORP.
NOTES
TO FINANCIAL STATEMENTS
Note
10 — Income Taxes
The
Company’s net deferred tax assets are as follows:
December 31
2022
Deferred tax asset
Net operating loss carryforward
$ —
Startup/Organization Expenses
112,138
Unrealized gain on investments held in trust account
( 78,955 )
Total deferred tax asset
33,183
Valuation allowance
( 112,138 )
Deferred tax asset (liability), net of allowance
$ ( 78,955 )
The
income tax provision consists of the following:
For the
Year ended
December 31,
2022
Federal
Current
$ 243,070
Deferred
( 33,183 )
State
Current
$ —
Deferred
—
Change in valuation allowance
112,138
Income tax provision
$ 322,025
A
reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate is as follows:
For the
Year ended
December 31,
2022
Income at U.S. statutory rate
21.00 %
State taxes, net of federal benefit
0.00 %
Change in fair value of warrants
( 7.51 )%
Change in valuation allowance
7.21 %
20.70 %
As
of December 31, 2022, the Company did not have any U.S. federal and state net operating loss carryovers available to offset future taxable
income.
F- 23
In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. The change
in the valuation allowance was $ 112,138 for the year ended December 31, 2022.
The provisions for U.S. federal and state income taxes were $ 322,025
(including deferred tax liability of $ 78,955 ) and $ 0 for the year ended December 31, 2022 and for the period from March 16, 2021 (inception)
to December 31, 2021, respectively. The Company’s tax returns for the year ended December 31, 2022 and 2021 remain open and subject
to examination.
Note
11 — Subsequent Events
In accordance with ASC 855, “Subsequent
Events,” the Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that
the financial statements were issued. Based on the review, management identified the following subsequent events that are required disclosure
in the financial statements.
On March 22, 2023, the Company issued an unsecured,
non-interest bearing promissory note in the principal amount of up to $ 150,000 to the Sponsor. The promissory note is payable upon the
closing of the Business Combination or the liquidation of the Company. The holder of the promissory note, in its sole discretion, may
convert any or all of the unpaid principal under the promissory note into private units of the Company, at a price of $ 10.00 per unit,
upon consummation of the Business Combination.
On March 30, 2023, the Company issued an unsecured,
non-interest bearing promissory note in the principal amount of up to $ 360,000 to the Sponsor. The promissory note is payable upon the
closing of the Business Combination or the liquidation of the Company. The holder of the promissory note, in its sole discretion, may
convert any or all of the unpaid principal under the promissory note into private units of the Company, at a price of $ 10.00 per unit,
upon consummation of the Business Combination.
On March 31, 2023, the Company held a special
meeting of stockholders, at which the Company’s stockholders approved (i) an amendment to the Company’s amended and restated
certificate of incorporation (the “Extension Amendment”) and (ii) an amendment (the “Trust Amendment”) to the
Investment Management Trust Agreement, dated March 30, 2022, by and between the Company and Continental Stock Transfer & Trust Company,
as trustee, extending the date by which the Company must consummate a Business Combination from April 4, 2023 to July 4, 2023, with the
ability to further extend the deadline on a monthly basis up to five times from July 4, 2023 to December 4, 2023. In connection with the
stockholders’ vote at the special meeting, an aggregate of 6,103,350 shares of the Company’s common stock were tendered for
redemption.
Subject upon stockholder approval of the Extension
Amendment and the Trust Amendment, the Sponsor, or any of their respective affiliates or designees, agreed to deposit into the Trust Account
$ 360,000 for the initial three-month extension and $ 120,000 per month for each subsequent one-month extension. The extension payment(s)
will bear no interest and will be repayable by the Company to the contributors upon consummation of the Business Combination. The loans
will be forgiven by the contributors if the Company is unable to consummate the Business Combination except to the extent of any funds
held outside of the Trust Account.
F-24
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.